Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor

Detalles Bibliográficos
Autores principales: Eskens, Ferry ALM, Haberkorn, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2012
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708150/
https://www.ncbi.nlm.nih.gov/pubmed/26812943
http://dx.doi.org/10.3978/j.issn.2223-4683.2012.06.02

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708150/
https://www.ncbi.nlm.nih.gov/pubmed/26812943
http://dx.doi.org/10.3978/j.issn.2223-4683.2012.06.02

Ejemplares similares